Type VII collagen is expressed but anchoring fibrils are defective in dystrophic epidermolysis bullosa inversa. 1990

L Bruckner-Tuderman, and K M Niemi, and M Kero, and U W Schnyder, and T Reunala
Department of Dermatology, University of Zurich, Switzerland.

A patient with dystrophic epidermolysis bullosa inversa was studied using electron microscopy and indirect immunofluorescence using antibodies to matrix macromolecules of the dermoepidermal junction zone. There was splitting below the lamina densa with an apparently normal basement membrane, but a lack of intact anchoring fibrils and with a disarranged papillary connective tissue. Indirect immunofluorescence examination with antibodies to type VII collagen, the major structural protein of anchoring fibrils, showed a normal linear staining pattern. Synthesis of type VII collagen which is unable to form stable, resistant anchoring fibrils may be a distinct feature of this subtype of recessive dystrophic epidermolysis bullosa.

UI MeSH Term Description Entries
D003094 Collagen A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH). Avicon,Avitene,Collagen Felt,Collagen Fleece,Collagenfleece,Collastat,Dermodress,Microfibril Collagen Hemostat,Pangen,Zyderm,alpha-Collagen,Collagen Hemostat, Microfibril,alpha Collagen
D004820 Epidermolysis Bullosa Group of genetically determined disorders characterized by the blistering of skin and mucosae. There are four major forms: acquired, simple, junctional, and dystrophic. Each of the latter three has several varieties. Acantholysis Bullosa
D005260 Female Females
D005455 Fluorescent Antibody Technique Test for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye (FLUORESCENT ANTIBODY TECHNIQUE, DIRECT) or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody (FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT). The tissue is then examined by fluorescence microscopy. Antinuclear Antibody Test, Fluorescent,Coon's Technique,Fluorescent Antinuclear Antibody Test,Fluorescent Protein Tracing,Immunofluorescence Technique,Coon's Technic,Fluorescent Antibody Technic,Immunofluorescence,Immunofluorescence Technic,Antibody Technic, Fluorescent,Antibody Technics, Fluorescent,Antibody Technique, Fluorescent,Antibody Techniques, Fluorescent,Coon Technic,Coon Technique,Coons Technic,Coons Technique,Fluorescent Antibody Technics,Fluorescent Antibody Techniques,Fluorescent Protein Tracings,Immunofluorescence Technics,Immunofluorescence Techniques,Protein Tracing, Fluorescent,Protein Tracings, Fluorescent,Technic, Coon's,Technic, Fluorescent Antibody,Technic, Immunofluorescence,Technics, Fluorescent Antibody,Technics, Immunofluorescence,Technique, Coon's,Technique, Fluorescent Antibody,Technique, Immunofluorescence,Techniques, Fluorescent Antibody,Techniques, Immunofluorescence,Tracing, Fluorescent Protein,Tracings, Fluorescent Protein
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012867 Skin The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.

Related Publications

L Bruckner-Tuderman, and K M Niemi, and M Kero, and U W Schnyder, and T Reunala
November 1992, The Journal of investigative dermatology,
L Bruckner-Tuderman, and K M Niemi, and M Kero, and U W Schnyder, and T Reunala
September 1993, The Journal of investigative dermatology,
L Bruckner-Tuderman, and K M Niemi, and M Kero, and U W Schnyder, and T Reunala
July 1989, The Journal of investigative dermatology,
L Bruckner-Tuderman, and K M Niemi, and M Kero, and U W Schnyder, and T Reunala
April 1993, The Journal of investigative dermatology,
L Bruckner-Tuderman, and K M Niemi, and M Kero, and U W Schnyder, and T Reunala
March 1992, The Journal of clinical investigation,
L Bruckner-Tuderman, and K M Niemi, and M Kero, and U W Schnyder, and T Reunala
January 2010, Dermatologic clinics,
L Bruckner-Tuderman, and K M Niemi, and M Kero, and U W Schnyder, and T Reunala
May 2011, The British journal of dermatology,
L Bruckner-Tuderman, and K M Niemi, and M Kero, and U W Schnyder, and T Reunala
March 2011, Journal of medical genetics,
L Bruckner-Tuderman, and K M Niemi, and M Kero, and U W Schnyder, and T Reunala
January 2009, Molecular therapy : the journal of the American Society of Gene Therapy,
L Bruckner-Tuderman, and K M Niemi, and M Kero, and U W Schnyder, and T Reunala
March 1991, Journal of the American Academy of Dermatology,
Copied contents to your clipboard!